Location History:
- Austin, TX (US) (2018)
- Raleigh, NC (US) (2020)
Company Filing History:
Years Active: 2018-2020
Title: Eman Ghanem: Innovator in Reverse Transcriptase Fusion Proteins
Introduction
Eman Ghanem is a notable inventor based in Austin, Texas, recognized for his contributions to the field of biotechnology. He holds three patents, showcasing his innovative work in the development of stabilized reverse transcriptase fusion proteins. His research has significant implications for nucleic acid amplification methods and cDNA synthesis.
Latest Patents
Ghanem's latest patents focus on stabilized reverse transcriptase fusion proteins. These proteins include a thermostable reverse transcriptase connected to a stabilizer protein. The attachment of the stabilizer protein enhances the stability of the fusion protein, aiding in its purification and increasing solubility. This innovation allows for longer storage and enables the fusion protein to be utilized under more rigorous conditions, such as higher temperatures. Additionally, the stabilized reverse transcriptase fusion proteins are suitable for various applications, including reverse transcription polymerase chain reaction and cDNA synthesis.
Career Highlights
Eman Ghanem is affiliated with the University of Texas System, where he continues to advance his research in biotechnology. His work has garnered attention for its potential to improve methodologies in genetic research and diagnostics.
Collaborations
Ghanem collaborates with esteemed colleagues, including Alan M. Lambowitz and Sabine Mohr, who contribute to his research endeavors. Their combined expertise enhances the impact of their work in the field.
Conclusion
Eman Ghanem's innovative contributions to stabilized reverse transcriptase fusion proteins mark him as a significant figure in biotechnology. His patents reflect a commitment to advancing scientific knowledge and improving practical applications in genetic research.